Company: CPMV
Filing Date: 2025-08-19
Form Type: 10-Q
Source: 0001683168-25-006318
Chunk: 52

Company: Mosaic ImmunoEngineering Inc.
Filing Date: 2025-08-19
Form: 10-Q
Item: Part II, Item 4
Chunk 52
---
 the Securities Exchange Act of 1934, the
registrant has duly caused this Report to be signed on its behalf by the undersigned thereunto duly authorized.

    Dated: August 19, 2025
    
    MOSAIC IMMUNOENGINEERING, INC.
     
    /s/ Steven King                                     
    
    Steven King. President, Chief Executive Officer, Director
    (Principal Executive Officer, Principal Financial Officer and
    Principal
    Accounting Officer)

 23